Methamidophos


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D001259 Ataxia PMID:22974967
MESH:D001342 Autonomic Nervous System Diseases PMID:11527224
MESH:D001919 Bradycardia PMID:26200596
MESH:D003866 Depressive Disorder PMID:19442833
MESH:D005517 Foodborne Diseases PMID:11527224
MESH:D007022 Hypotension PMID:26200596
MESH:D007248 Infertility, Male PMID:10828210
MESH:D009422 Nervous System Diseases PMID:15938848; PMID:2238440
MESH:D010523 Peripheral Nervous System Diseases PMID:10447555; PMID:2170085; PMID:7654138
MESH:D011041 Poisoning PMID:16119251; PMID:17849254; PMID:19778260; PMID:22542756
MESH:D011115 Polyneuropathies PMID:7654138
MESH:D012798 Sialorrhea PMID:26200596
MESH:D015431 Weight Loss PMID:23125138
MESH:D015877 Miosis PMID:26200596
MESH:D018908 Muscle Weakness PMID:17849254
MESH:D019457 Chromosome Breakage PMID:23125138; PMID:26688254
MESH:D019954 Neurobehavioral Manifestations PMID:26200596
MESH:D020258 Neurotoxicity Syndromes PMID:15895843
MESH:D062025 Organophosphate Poisoning PMID:18070496; PMID:26200596; PMID:30602960

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.